477 related articles for article (PubMed ID: 16413722)
1. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): the challenge of a new consensus conference].
Chidiac C
Med Mal Infect; 2006 Jan; 36(1):1-3. PubMed ID: 16413722
[No Abstract] [Full Text] [Related]
2. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): The challenge of a new consensus conference].
Chidiac C
Med Mal Infect; 2006; 36(11-12):535-7. PubMed ID: 17137740
[No Abstract] [Full Text] [Related]
3. [15th Consensus Conference on anti-infectious treatments: management of viral infections of the lower respiratory tract in the immunocompetent adult. Short text].
; ; ; ; ; ; ; ;
Rev Pneumol Clin; 2007 Feb; 63(1):7-18. PubMed ID: 17457279
[No Abstract] [Full Text] [Related]
4. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
5. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
6. [Initial empirical antibiotic treatment of community-acquired pneumonia].
Frías J; Gomis M; Prieto J; Mensa J; Bouza E; García-Rodríguez JA; Torres A; Dorca J; Zalacaín R; García de Lomas J
Rev Esp Quimioter; 1998 Sep; 11(3):255-61. PubMed ID: 9795313
[No Abstract] [Full Text] [Related]
7. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].
Höffken G; Lorenz J; Kern W; Welte T; Bauer T; Dalhoff K; Dietrich E; Ewig S; Gastmeier P; Grabein B; Halle E; Kolditz M; Marre R; Sitter H
Dtsch Med Wochenschr; 2010 Feb; 135(8):359-65. PubMed ID: 20166002
[No Abstract] [Full Text] [Related]
9. Antimicrobial resistance and treatment of community-acquired pneumonia.
Mandell LA
Clin Chest Med; 2005 Mar; 26(1):57-64. PubMed ID: 15802166
[TBL] [Abstract][Full Text] [Related]
10. [New quinolones for the treatment of community-acquired pneumonia--pro].
Zimmerli S
Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
[No Abstract] [Full Text] [Related]
11. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
12. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
Blot S; Depuydt P
Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
[No Abstract] [Full Text] [Related]
13. Timely antibiotic therapy for community-acquired pneumonia.
Mansel JK
J Miss State Med Assoc; 2004 May; 45(5):159. PubMed ID: 15162706
[No Abstract] [Full Text] [Related]
14. [Comments on the XV(e) consensus conference: "Managing low tract respiratory infections in the immunocompetent adult"].
Carlet J
Med Mal Infect; 2007 Jan; 37(1):69-70. PubMed ID: 17145151
[No Abstract] [Full Text] [Related]
15. Primary care challenges in the management of respiratory tract infections.
JAAPA; 2006 Sep; Suppl():4-14; quiz 15-6. PubMed ID: 17001773
[TBL] [Abstract][Full Text] [Related]
16. [Community-acquired pneumonia--treatment perspectives in the physician's office].
Ewig S
MMW Fortschr Med; 2004 May; 146(21):43-5. PubMed ID: 15373084
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Lee WK; Young BW
J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
[No Abstract] [Full Text] [Related]
18. Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
Jenkins TC; Sakai J; Knepper BC; Swartwood CJ; Haukoos JS; Long JA; Price CS; Burman WJ
Acad Emerg Med; 2012 Jun; 19(6):703-6. PubMed ID: 22632455
[TBL] [Abstract][Full Text] [Related]
19. Short-course beta-lactam treatment for community-acquired pneumonia.
Stralin K; Sjöberg L; Holmberg H
Clin Infect Dis; 2004 Mar; 38(5):766-7. PubMed ID: 14986269
[No Abstract] [Full Text] [Related]
20. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
